IDEAS home Printed from https://ideas.repec.org/a/bpj/ijbist/v6y2010i1n34.html
   My bibliography  Save this article

Survival Models in Health Economic Evaluations: Balancing Fit and Parsimony to Improve Prediction

Author

Listed:
  • Jackson Christopher H

    (MRC Biostatistics Unit)

  • Sharples Linda D

    (MRC Biostatistics Unit)

  • Thompson Simon G

    (MRC Biostatistics Unit)

Abstract

Health economic decision models compare costs and health effects of different interventions over the long term and usually incorporate survival data. Since survival is often extrapolated beyond the range of the data, inaccurate model specification can result in very different policy decisions. However, in this area, flexible survival models are rarely considered, and model uncertainty is rarely accounted for. In this article, various survival distributions are applied in a decision model for oral cancer screening. Flexible parametric models are compared with Bayesian semiparametric models, in which the baseline hazard can be made arbitrarily complex while still enabling survival to be extrapolated. A fully Bayesian framework is used for all models so that uncertainties can be easily incorporated in estimates of long-term costs and effects. The fit and predictive ability of both parametric and semiparametric models are compared using the deviance information criterion in order to account for model uncertainty in the cost-effectiveness analysis. Under the Bayesian semiparametric models, some smoothing of the hazard function is required to obtain adequate predictive ability and avoid sensitivity to the choice of prior. We determine that one flexible parametric survival model fits substantially better than the others considered in the oral cancer example.

Suggested Citation

  • Jackson Christopher H & Sharples Linda D & Thompson Simon G, 2010. "Survival Models in Health Economic Evaluations: Balancing Fit and Parsimony to Improve Prediction," The International Journal of Biostatistics, De Gruyter, vol. 6(1), pages 1-31, October.
  • Handle: RePEc:bpj:ijbist:v:6:y:2010:i:1:n:34
    DOI: 10.2202/1557-4679.1269
    as

    Download full text from publisher

    File URL: https://doi.org/10.2202/1557-4679.1269
    Download Restriction: For access to full text, subscription to the journal or payment for the individual article is required.

    File URL: https://libkey.io/10.2202/1557-4679.1269?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. A. E. Ades & Karl Claxton & Mark Sculpher, 2006. "Evidence synthesis, parameter correlation and probabilistic sensitivity analysis," Health Economics, John Wiley & Sons, Ltd., vol. 15(4), pages 373-381, April.
    2. Francisco Louzada-Neto, 1999. "Polyhazard Models for Lifetime Data," Biometrics, The International Biometric Society, vol. 55(4), pages 1281-1285, December.
    3. Maria De Iorio & Wesley O. Johnson & Peter Müller & Gary L. Rosner, 2009. "Bayesian Nonparametric Nonproportional Hazards Survival Modeling," Biometrics, The International Biometric Society, vol. 65(3), pages 762-771, September.
    4. Claxton, Karl, 1999. "The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies," Journal of Health Economics, Elsevier, vol. 18(3), pages 341-364, June.
    5. Stephen Walker & Bani K. Mallick, 1999. "A Bayesian Semiparametric Accelerated Failure Time Model," Biometrics, The International Biometric Society, vol. 55(2), pages 477-483, June.
    6. Briggs, Andrew & Sculpher, Mark & Claxton, Karl, 2006. "Decision Modelling for Health Economic Evaluation," OUP Catalogue, Oxford University Press, number 9780198526629.
    7. Christopher H. Jackson & Linda D. Sharples & Simon G. Thompson, 2010. "Structural and parameter uncertainty in Bayesian cost‐effectiveness models," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 59(2), pages 233-253, March.
    8. David J. Spiegelhalter & Nicola G. Best & Bradley P. Carlin & Angelika Van Der Linde, 2002. "Bayesian measures of model complexity and fit," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 64(4), pages 583-639, October.
    9. Christopher H. Jackson & Simon G. Thompson & Linda D. Sharples, 2009. "Accounting for uncertainty in health economic decision models by using model averaging," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 172(2), pages 383-404, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Béranger Lueza & Audrey Mauguen & Jean-Pierre Pignon & Oliver Rivero-Arias & Julia Bonastre & MAR-LC Collaborative Group, 2016. "Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study," PLOS ONE, Public Library of Science, vol. 11(3), pages 1-12, March.
    2. Xiaohui Zeng & Jianhe Li & Liubao Peng & Yunhua Wang & Chongqing Tan & Gannong Chen & Xiaomin Wan & Qiong Lu & Lidan Yi, 2014. "Economic Outcomes of Maintenance Gefitinib for Locally Advanced/Metastatic Non-Small-Cell Lung Cancer with Unknown EGFR Mutations: A Semi-Markov Model Analysis," PLOS ONE, Public Library of Science, vol. 9(2), pages 1-9, February.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Andrea Gabrio & Michael J. Daniels & Gianluca Baio, 2020. "A Bayesian parametric approach to handle missing longitudinal outcome data in trial‐based health economic evaluations," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 183(2), pages 607-629, February.
    2. Andrija S Grustam & Nasuh Buyukkaramikli & Ron Koymans & Hubertus J M Vrijhoef & Johan L Severens, 2019. "Value of information analysis in telehealth for chronic heart failure management," PLOS ONE, Public Library of Science, vol. 14(6), pages 1-23, June.
    3. Christopher H. Jackson & Linda D. Sharples & Simon G. Thompson, 2010. "Structural and parameter uncertainty in Bayesian cost‐effectiveness models," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 59(2), pages 233-253, March.
    4. Qi Cao & Erik Buskens & Hans L. Hillege & Tiny Jaarsma & Maarten Postma & Douwe Postmus, 2019. "Stratified treatment recommendation or one-size-fits-all? A health economic insight based on graphical exploration," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 475-482, April.
    5. Isaac Corro Ramos & Maureen P. M. H. Rutten-van Mölken & Maiwenn J. Al, 2013. "The Role of Value-of-Information Analysis in a Health Care Research Priority Setting," Medical Decision Making, , vol. 33(4), pages 472-489, May.
    6. Claire McKenna & Karl Claxton, 2011. "Addressing Adoption and Research Design Decisions Simultaneously," Medical Decision Making, , vol. 31(6), pages 853-865, November.
    7. Kasper M. Johannesen & Karl Claxton & Mark J. Sculpher & Allan J. Wailoo, 2018. "How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework," Health Economics, John Wiley & Sons, Ltd., vol. 27(2), pages 41-54, February.
    8. Hawre Jalal & Jeremy D. Goldhaber-Fiebert & Karen M. Kuntz, 2015. "Computing Expected Value of Partial Sample Information from Probabilistic Sensitivity Analysis Using Linear Regression Metamodeling," Medical Decision Making, , vol. 35(5), pages 584-595, July.
    9. Anna Heath, 2022. "Calculating Expected Value of Sample Information Adjusting for Imperfect Implementation," Medical Decision Making, , vol. 42(5), pages 626-636, July.
    10. Christopher H. Jackson & Simon G. Thompson & Linda D. Sharples, 2009. "Accounting for uncertainty in health economic decision models by using model averaging," Journal of the Royal Statistical Society Series A, Royal Statistical Society, vol. 172(2), pages 383-404, April.
    11. Kumar Prabhash & Vijay M Patil & Vanita Noronha & Amit Joshi & Atanu Bhattacharjee, 2016. "Bayesian Accelerated Failure Time And Its Application In Chemotherapy Drug Treatment Trial," Statistics in Transition New Series, Polish Statistical Association, vol. 17(4), pages 671-690, December.
    12. Simon Walker & Mark Sculpher & Karl Claxton & Steve Palmer, 2012. "Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions," Working Papers 077cherp, Centre for Health Economics, University of York.
    13. Li, Li & Hanson, Timothy E., 2014. "A Bayesian semiparametric regression model for reliability data using effective age," Computational Statistics & Data Analysis, Elsevier, vol. 73(C), pages 177-188.
    14. Christopher H. Jackson & Laura Bojke & Simon G. Thompson & Karl Claxton & Linda D. Sharples, 2011. "A Framework for Addressing Structural Uncertainty in Decision Models," Medical Decision Making, , vol. 31(4), pages 662-674, July.
    15. Christopher H. Jackson & Mark Jit & Linda D. Sharples & Daniela De Angelis, 2015. "Calibration of Complex Models through Bayesian Evidence Synthesis," Medical Decision Making, , vol. 35(2), pages 148-161, February.
    16. Hester V Eeren & Saskia J Schawo & Ron H J Scholte & Jan J V Busschbach & Leona Hakkaart, 2015. "Value of Information Analysis Applied to the Economic Evaluation of Interventions Aimed at Reducing Juvenile Delinquency: An Illustration," PLOS ONE, Public Library of Science, vol. 10(7), pages 1-15, July.
    17. Marta O Soares & L Canto e Castro, 2010. "Simulation or cohort models? Continuous time simulation and discretized Markov models to estimate cost-effectiveness," Working Papers 056cherp, Centre for Health Economics, University of York.
    18. Kurtis Shuler & Samuel Verbanic & Irene A. Chen & Juhee Lee, 2021. "A Bayesian nonparametric analysis for zero‐inflated multivariate count data with application to microbiome study," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 70(4), pages 961-979, August.
    19. Michał Jakubczyk & Bogumił Kamiński, 2017. "Fuzzy approach to decision analysis with multiple criteria and uncertainty in health technology assessment," Annals of Operations Research, Springer, vol. 251(1), pages 301-324, April.
    20. WH Rogowski, 2013. "An Economic Theory Of The Fourth Hurdle," Health Economics, John Wiley & Sons, Ltd., vol. 22(5), pages 600-610, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bpj:ijbist:v:6:y:2010:i:1:n:34. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Peter Golla (email available below). General contact details of provider: https://www.degruyter.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.